Savy Nadia, Brossier David, Brunel-Guitton Catherine, Ducharme-Crevier Laurence, Du Pont-Thibodeau Geneviève, Jouvet Philippe
Department of Pediatrics, CHU Sainte-Justine, University of Montreal, Montreal, QC, Canada,
Department of Pediatrics, Pediatric Intensive Care Unit, CHU Caen, Caen, France.
Hepat Med. 2018 Sep 12;10:105-115. doi: 10.2147/HMER.S140711. eCollection 2018.
Acute hyperammonemia may induce a neurologic impairment leading to an acute life-threatening condition. Coma duration, ammonia peak level, and hyperammonemia duration are the main risk factors of hyperammonemia-related neurologic deficits and death. In children, hyperammonemia is mainly caused by severe liver failure and inborn errors of metabolism. In an acute setting, obtaining reliable plasma ammonia levels can be challenging because of the preanalytical difficulties that need to be addressed carefully. The management of hyperammonemia includes 1) identification of precipitating factors and cerebral edema presence, 2) a decrease in ammonia production by reducing protein intake and reversing catabolism, and 3) ammonia removal with pharmacologic treatment and, in the most severe cases, with extracorporeal therapies. In case of severe coma, transcranial Doppler ultrasound could be the method of choice to noninvasively monitor cerebral blood flow and titrate therapies.
急性高氨血症可能导致神经功能损害,进而引发危及生命的急症。昏迷持续时间、血氨峰值水平和高氨血症持续时间是高氨血症相关神经功能缺损和死亡的主要危险因素。在儿童中,高氨血症主要由严重肝功能衰竭和先天性代谢缺陷引起。在急性情况下,由于需要仔细处理分析前的困难,获得可靠的血浆氨水平可能具有挑战性。高氨血症的治疗包括:1)识别诱发因素和是否存在脑水肿;2)通过减少蛋白质摄入和逆转分解代谢来减少氨的产生;3)采用药物治疗去除氨,在最严重的情况下,采用体外治疗。在严重昏迷的情况下,经颅多普勒超声可能是无创监测脑血流和调整治疗的首选方法。